Bobillo S, Joffe E, Lavery JA, et al. Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era. Blood. 2021;137(1):39-48.

doi:10.1182/blood.2021015316

Bobillo S, Joffe E, Lavery JA, et al. Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era. Blood. 2021;137(1):39-48.

Blood (2022) 139 (11): 1772.

https://doi.org/10.1182/blood.2021015316

In “Acknowledgments” on page 47, National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30CA008748 should have been cited. The error has been corrected in the online version of the article.

2022

Bobillo S, Joffe E, Lavery JA, et al. Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era. Blood. 2021;137(1):39-48.

Contents

Data & Figures

Supplemental data

References

Cited By

Email alerts

ASH Publications

American Society of Hematology